A61K 9/0043
Nose
Official title: {Nose}
A61K9/0043 (Nose) appears on 2,394 US grants and 4,622 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,394
- Published applications
- 4,622
- Assignees
- 1,942
- Inventors
- 6,417
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 5 | 0 |
| 1985 | 3 | 0 |
| 1986 | 5 | 0 |
| 1987 | 4 | 0 |
| 1988 | 11 | 0 |
| 1989 | 8 | 0 |
| 1990 | 10 | 0 |
| 1991 | 11 | 0 |
| 1992 | 14 | 0 |
| 1993 | 9 | 0 |
| 1994 | 4 | 0 |
| 1995 | 16 | 0 |
| 1996 | 22 | 0 |
| 1997 | 21 | 0 |
| 1998 | 31 | 0 |
| 1999 | 41 | 0 |
| 2000 | 26 | 0 |
| 2001 | 37 | 27 |
| 2002 | 49 | 73 |
| 2003 | 39 | 97 |
| 2004 | 41 | 109 |
| 2005 | 24 | 102 |
| 2006 | 27 | 113 |
| 2007 | 30 | 133 |
| 2008 | 22 | 105 |
| 2009 | 23 | 137 |
| 2010 | 43 | 129 |
| 2011 | 66 | 130 |
| 2012 | 83 | 123 |
| 2013 | 77 | 123 |
| 2014 | 100 | 189 |
| 2015 | 88 | 165 |
| 2016 | 100 | 192 |
| 2017 | 122 | 224 |
| 2018 | 118 | 202 |
| 2019 | 123 | 246 |
| 2020 | 117 | 305 |
| 2021 | 160 | 329 |
| 2022 | 157 | 285 |
| 2023 | 147 | 350 |
| 2024 | 120 | 295 |
| 2025 | 141 | 231 |
| 2026 | 86 | 208 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cell-receptor targeted exosomes6 Oct 2026US 12,751,930 B2City of Hope
- Compositions, methods, systems and kits for the treatment of nosebleeds6 Oct 2026US 12,751,967 B2Advanced Rx
- Quinine and its use to generate innate immune response29 Sep 2026US 12,746,236 B2The Trustees of the University of Pennsylvania
- Intranasal administration of ketamine to cluster headache patients15 Sep 2026US 12,734,136 B2Afyx Development A/S
- D-amphetamine compounds, compositions, and processes for making and using the same15 Sep 2026US 12,735,388 B2Zevra Therapeutics, Inc.
- Esketamine formulations and methods for preparation and storage8 Oct 2026US 2026/0306360 A1Janssen Pharmaceutica NV
- Perfluorocarbon compositions, systems, and methods for ischemic, inflammatory, infectuous, transplant, and other medical conditions8 Oct 2026US 2026/0306422 A1
- 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) pharmaceutical compositions8 Oct 2026US 2026/0306452 A1Beckley Psytech Limited
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- Intranasal delivery of cd34+ cells for the treatment of stroke8 Oct 2026US 2026/0306537 A1Cellprothera
Most cited
By later US patents
- Tamper-resistant oral opioid agonist formulations343US 6,696,088 B2Euro-Celtique S. A. · 2004
- Method of administering narcotic antagonists and analgesics and novel dosage forms containing same273US 4,464,378 AUniversity of Kentucky Research Foundation · 1984
- Powdery pharmaceutical composition for nasal administration248US 4,613,500 ATeijin Limited · 1986
- Materials and methods for enhancing cellular internalization248US 5,985,320 AThe Penn State Research Foundation · 1999
- Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches224US 6,432,986 B12002